Acrivon Therapeutics Inc

NASDAQ:ACRV   3:59:52 PM EDT
22.55
+0.42 (+1.90%)
5:10:43 PM EDT: $21.80 -0.75 (-3.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Acrivon Therapeutics Inc Stock, NASDAQ:ACRV

480 Arsenal Way, Suite 100, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.207.8979
Number of Employees:

Description

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform, called Acrivon Predictive Precision Proteomics (AP3), for development of drug pipeline. Its AP3 is used to generate proprietary OncoSignature companion diagnostics to identify the patients who will benefit from the medicines. The company was founded by Peter Blume-Jensen and Kristina Masson on March 03, 2018 and is headquartered in Watertown, MA.